Ce site a été mis à jour le 14 mars 2017

Osteoporosis Imprimer
We recently updated you with the information that no increase had been observed in the risk of oesophageal cancer and gastric cancer in patients who were exposed to biphosphonates compared to controls Cardwell et al JAMA. 2010;304(6):657-663. doi:10.1001/jama.2010.1098.
This is in contrast to what Green et al observed (Green et al BMJ Published 2 September 2010) using the same database but for a longer period (4.5 years vs 7.7 years) Green et al found that one (or more) prescription for oral bisphosphonates increased the risk of oesophageal cancer by 30%; 10 or more prescriptions nearly doubled the risk. No increased risk was found for cancers of the stomach or colorectum. Still the absolute numbers would remain small. Of course, these contradictory data warrant that physicians stress evenmore the importance of taking the drug with the necessary precautions and stop taking it if side effects occur.

SHARING-OBGYN is a service that I intend to share with you. The idea is to send one short email message a day concerning an article that appeared recently and might be of interest to you.
The selection of the articles is arbitrary, but there are no commercial interests involved and no conflict of interest.
If you want to be removed from the list of persons to whom these emails are sent please let me know.
If you want to bring comments or add email addresses of friends or colleagues, please feel free to do so.

Next Meeting Belgian Menopause Society -
Octobre 2th 2010:
"The Menopause Mythology : having sex after fifty : Men love their drug, are women still waiting for theirs?"

November 13th 2010 will be
"Update in Postmenopausal Osteoporosis"

Сделайте правильный выбор! Онлайн или реальные слоты? Играйте на реальные деньги!
займ онлайн